Silent but significant: subclinical cardiovascular changes in paediatric Behçet's disease

Ilyas Bingöl1, Hafize Emine Sönmez2, Sümeyra Doğan3

  • 1Department of Paediatrics, University of Health Science, Kanuni Sultan Süleyman Education and Research Hospital, Istanbul, Turkey. drilyasbingol@hotmail.com.

Insights

Paediatric Behçet's disease (BD) shows early cardiovascular changes like diastolic dysfunction and increased pulmonary arterial pressure. Routine screening is recommended to manage long-term risks in children with BD.

Area of Science:

  • Rheumatology
  • Cardiology
  • Pediatrics

Background:

  • Behçet's disease (BD) is a systemic autoinflammatory vasculitis with multisystemic effects.
  • Cardiovascular complications are known in adult BD but are underexplored in children.
  • Paediatric BD requires investigation for early cardiovascular involvement.

Purpose of the Study:

  • To assess cardiovascular manifestations in paediatric Behçet's disease.
  • To evaluate cardiac function, vascular stiffness, and microvascular changes.
  • To identify early signs of cardiovascular disease in children with BD.

Main Methods:

  • A cohort of 29 paediatric BD patients and 29 healthy controls was studied.
  • Echocardiography assessed cardiac parameters and pulmonary vascular resistance.
  • Capillaroscopy and carotid artery intima-media thickness (CIMT) evaluated microvascular and vascular changes.

Main Results:

  • Paediatric BD patients exhibited elevated left ventricular myocardial performance index (LV MPI) and reduced right ventricular systolic function.
  • Increased pulmonary arterial pressure and aortic stiffness were observed, suggesting early vascular remodelling.
  • No significant differences in CIMT were found, but mild capillary tortuosity was noted in some patients.

Conclusions:

  • Early cardiovascular changes, including diastolic dysfunction and impaired aortic elasticity, are present in paediatric BD.
  • Routine cardiovascular screening is crucial for children with BD to mitigate long-term risks.
  • Further research is needed to understand the progression and optimize interventions for these abnormalities.
Abstract

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
414
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
482
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
552
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
467
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
433
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
401